Effects of Aprepitant and dexamethasone in prevention of nausea and vomiting after laparoscopic cholecystectomy
Not Applicable
- Conditions
- Health Condition 1: K802- Calculus of gallbladder without cholecystitis
- Registration Number
- CTRI/2022/10/046372
- Lead Sponsor
- Intramural project funded by Research cell of Rajendra Institute Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA GRADE I & II PATIENTS SCHEDULED FOR ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY SURGERY
Exclusion Criteria
PATIENTS WHO HAD A HISTORY OF DRUG ABUSE, HYPERSENSITIVITY REACTION, NAUSEA AND RECEIVED ANTIEMETIC BEFORE SURGERY WITHIN 24 HOURS, PREGNANCY, BREASTFEEDING STATUS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary efficacy variable will be episodes of nausea and vomiting in the early and late postoperative period in first 24 hours. <br/ ><br>Timepoint: first 24 hours after surgery. <br/ ><br>
- Secondary Outcome Measures
Name Time Method <br/ ><br>The incidence of any adverse reaction to treatment in the two experimental groups will be recorded <br/ ><br>Timepoint: 24 hours